Recurrent Ovarian Germ Cell Tumor Completed Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01652794Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerTreatment